11 datasets were done for this analysis

Datasets with this analysis

This table only shows the unique datasets. The dataset page shows more informations, and the analysis results of this dataset.

Dataset	Source	Tissue	Cancer type level1	Cancer type level2	Drug type	Regimen
GSE169246_PacBlood	patients	Peripheral blood mononuclear cells	Breast cancer	advanced triple-negative breast cancer (TNBC)	Chemotherapy	paclitaxel
GSE169246_PacTissue	patients	Tumor tissue	Breast cancer	advanced triple-negative breast cancer (TNBC)	Chemotherapy	paclitaxel
GSE197268_Axi-cel	patients	Peripheral blood mononuclear cells	Acute lymphoblastic leukemia	large B-ALL	Immunotherapy	axi-cel (CAR-T)
GSE197268_Tisa-cel	patients	Peripheral blood mononuclear cells	Acute lymphoblastic leukemia	large B-ALL	Immunotherapy	tisa-cel (CAR-T)
GSE169246_PacAteBlood	patients	Peripheral blood mononuclear cells	Breast cancer	advanced triple-negative breast cancer (TNBC)	Immunotherapy	atezolizumab + paclitaxel
GSE169246_PacAteTissue	patients	Tumor tissue	Breast cancer	advanced triple-negative breast cancer (TNBC)	Immunotherapy	atezolizumab + paclitaxel
GSE212217	patients	Peripheral blood mononuclear cells	Endometrial cancer	epigenetic MMRd endometrial carcinoma	Immunotherapy	pembrolizumab
GSE162117	patients	Peripheral blood mononuclear cells	Acute myeloid leukemia	refractory AML	Targeted therapy	ficlatuzumab
GSE199333	patients	Bone marrow aspirate	Acute myeloid leukemia	primary FLT3-ITD-mutated AML	Targeted therapy	gilteritinib
GSE161801_IMiD	patients	Bone marrow aspirate	Multiple myeloma	refractory MM	Targeted therapy	pomalidomide + dexamethasone OR lenalidomide + dexamethasone
GSE189460	patients	Bone marrow aspirate	Multiple myeloma	MM	Targeted therapy	bortezomib + melphalan + prednisolone